Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
01/22/2008 | CA2374362C Urea derivatives as hiv aspartyl protease inhibitors |
01/22/2008 | CA2374247C Heterocyclic derivatives useful as anticancer agents |
01/22/2008 | CA2293553C Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase |
01/22/2008 | CA2214321C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
01/17/2008 | WO2008007780A1 Pentadienamide derivative |
01/17/2008 | WO2008006873A1 Fungicide hydroximoyl-tetrazole derivatives |
01/17/2008 | WO2008006790A1 Indole compounds |
01/17/2008 | WO2008006454A1 Electroluminescent polymers and use thereof |
01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
01/17/2008 | WO2007139816A3 Thiophene-carboxamides useful as inhibitors of protein kinases |
01/17/2008 | WO2007113202A8 Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists |
01/17/2008 | WO2007084413B1 Methods for treating hepatitis c |
01/17/2008 | WO2006056930A3 Novel 4 -aminopiperidine derivatives as plasmepsin ii inhibitors |
01/17/2008 | US20080015243 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
01/17/2008 | US20080015235 Histamine H3 Receptor Inhibitors, Preparation and Therapeutic Uses |
01/17/2008 | US20080015231 Therapeutic compounds |
01/17/2008 | US20080015220 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma |
01/17/2008 | US20080015199 Triazolone derivatives |
01/17/2008 | US20080015198 Moderate cannabinoid receptors; eating disorders; drug abuse; central nervous system disorders ; anticancer agents; bone disorders; Alzheimer's disease |
01/17/2008 | US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds |
01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
01/17/2008 | DE102006032824A1 Substituierte Indazole Substituted indazoles |
01/17/2008 | DE102006031224A1 New sulfoximine-substituted pyrimidines useful for treating e.g. diseases caused by inflammatory, allergic or proliferative processes, oncological diseases, cancer, eye, autoimmune and neurodegerative diseases |
01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
01/17/2008 | CA2659121A1 Therapeutic compounds |
01/17/2008 | CA2658097A1 Pentadienamide derivatives |
01/17/2008 | CA2657719A1 Cyclopentane derivatives as antiglaucoma agents |
01/17/2008 | CA2653589A1 Fungicide hydroximoyl-tetrazole derivatives |
01/16/2008 | EP1878733A1 Pyrimidine derivatives as ALK-5 inhibitors |
01/16/2008 | EP1878728A2 Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders |
01/16/2008 | EP1878725A2 Pyrimidine derivatives and their use as CB2 modulators |
01/16/2008 | EP1878723A1 N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide derivatives antagonists of the CB1 cannabinoids receptors |
01/16/2008 | EP1877495A2 Reactive azo dyes, methods for the production thereof and their use |
01/16/2008 | EP1877404A2 Novel cyclic amines |
01/16/2008 | EP1877398A1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
01/16/2008 | EP1877386A1 Herbicidally active phenylsulphonyl-urea |
01/16/2008 | EP1877383A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
01/16/2008 | EP1877378A2 Oxindole compounds and their uses as therapeutic agents |
01/16/2008 | EP1713778B1 Benzazepine derivatives as histamine h3 antagonists |
01/16/2008 | EP1601659B1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
01/16/2008 | EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists |
01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
01/16/2008 | EP1122242B1 Cyanophenyl derivatives |
01/16/2008 | CN101104604A Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis |
01/16/2008 | CN100361990C Second order non-linear optical chromophore containing indolyl radical and its prepn and application |
01/15/2008 | US7319153 Solubility, oxidative stability, resistance to dimerization, mobility comparable to other organic semiconductors when formed into a semiconductive layer, thin film transistors |
01/15/2008 | US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists |
01/15/2008 | US7319104 hPPARs activators |
01/15/2008 | US7319097 Treatment of type II diabetes with benzenesulfonamide substituted with an N-heterocycle: N-[2-amino-5-(1,4-diazepan-1-yl)phenyl]benzenesulfonamide, N-[4-amino-5-(piperazinyl)phenyl]benzenesulfonamide, 3-amino-4-(5-methyl-2,5-diaza-bicyclo[2.2.1]hept-2-yl)-N-phenyl-benzenesulfonamide hydrochloride |
01/15/2008 | US7319084 An addition polymerization catalyst of a cationic transition metal complex of a neutral bidentate ligand including a pyrole ring and an anion or nickelbis(1,5-cyclooctadiene), tri(pentafluorophenyl)borane and the neutral bidentate ligand; heat resistance; stability; steric hinderance for process control |
01/15/2008 | US7318966 Luminescent element material and luminescent element comprising the same |
01/15/2008 | US7318823 Methods for repairing damaged intervertebral discs |
01/15/2008 | CA2218479C 1,4-di-substituted piperidine derivatives |
01/10/2008 | WO2008006040A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
01/10/2008 | WO2008006032A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
01/10/2008 | WO2008005954A2 Tryphostin-analogs for the treatment of cell proliferative diseases |
01/10/2008 | WO2008005423A1 Improved method of making sufentanil |
01/10/2008 | WO2008005268A1 Substituted piperidines that increase p53 activity and the uses thereof |
01/10/2008 | WO2008004946A1 New pyridine analogues |
01/10/2008 | WO2008004943A1 New pyridine analogues |
01/10/2008 | WO2008004096A1 Pyrazole derivatives as cytochrome p450 inhibitors |
01/10/2008 | WO2008003741A1 N- [ (pyridin- 2 -yl) methoxy]heterocyclyl carboxamide derivatives and related compounds as fungicides |
01/10/2008 | WO2008003665A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
01/10/2008 | WO2008003607A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
01/10/2008 | WO2008003452A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
01/10/2008 | WO2007131764A3 New heterocyclic compounds for the inhibition of integrins and use thereof |
01/10/2008 | WO2007109334A3 Sip receptor modulating compounds and use thereof |
01/10/2008 | WO2007050425A3 Lxr modulators |
01/10/2008 | US20080009625 6,13-bis(triisopropylsilylethynyl)pentacene, use in in various electronic devices and in a formulation for ink jet printing and in an organic field effect transistors |
01/10/2008 | US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes |
01/10/2008 | US20080009488 protein kinase inhibitors such as Methyl {5-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-1H-benzimidazol-2-yl}carbamate, used to modulate cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion |
01/10/2008 | US20080008708 Tyrosine kinase inhibitors |
01/10/2008 | CA2660031A1 Pyrazole derivatives as cytochrome p450 inhibitors |
01/10/2008 | CA2656622A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
01/10/2008 | CA2656618A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
01/10/2008 | CA2656597A1 New pyridine analogues |
01/10/2008 | CA2656398A1 Substituted piperidines that increase p53 activity and the uses thereof |
01/10/2008 | CA2655680A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
01/10/2008 | CA2655633A1 New pyridine analogues |
01/10/2008 | CA2654246A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
01/09/2008 | EP1876174A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
01/09/2008 | EP1874761A2 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors |
01/09/2008 | EP1874736A2 Fused heterocyclic compounds |
01/09/2008 | EP1874721A2 Glycine transport inhibitors |
01/09/2008 | EP1874303A1 Pyrazole compounds as prostaglandin receptors ligands |
01/09/2008 | EP1653950B1 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
01/09/2008 | EP1638934B1 3-aminopyrrolidines as inhibitors of monoamine uptake |
01/09/2008 | EP1583756B9 Thiophene carboxamides as inhibitors of the enzyme ikk-2 |
01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
01/09/2008 | CN101103028A Heteroaryl substituted quinolin-4-ylamine analogues |
01/09/2008 | CN101103014A N-heterocyclyl phthalic acid diamides as insecticides |
01/09/2008 | CN101103002A 3,4,(5)-substituted tetrahydropyridines |
01/09/2008 | CN100360524C Multi-functional thioxanthone photoinitiators |
01/09/2008 | CN100360522C Novel compounds having selective inhibiting effect at GSK3 |
01/09/2008 | CN100360521C 4,4-disubstituted piperidine derivatives having CCR3 antagonism |